Related Experiment Video
Updated: Jan 5, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.7K
Pathways of Colorectal Carcinogenesis
Long H Nguyen1, Ajay Goel2, Daniel C Chung3
1Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Gastroenterology
|October 18, 2019
Summary
Colorectal cancer arises from genetic and epigenetic changes. Understanding these alterations, including DNA repair defects and instability pathways, reveals distinct tumor subgroups linked to patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a complex disease driven by accumulating genetic and epigenetic alterations.
- Understanding the molecular basis of CRC progression from adenoma to carcinoma is crucial for improving patient outcomes.
Purpose of the Study:
- To review the genetic and epigenetic alterations in colorectal cancer development.
- To explore the molecular mechanisms including DNA repair, chromosomal instability, microsatellite instability, serrated pathway, and DNA methylation.
- To identify distinct molecular subgroups of CRC and their association with patient prognosis.
Main Methods:
- Literature review of genetic and epigenetic alterations in colorectal cancer.
- Analysis of molecular mechanisms driving colorectal tumor development and progression.
- Correlation of molecular subgroups with clinical outcomes.
Main Results:
- Colorectal cancer develops through stepwise accumulation of genetic and epigenetic changes.
- Defects in DNA repair, chromosome instability, microsatellite instability, and alterations in the serrated pathway and DNA methylation are key mechanisms.
- Distinct molecular subgroups of colorectal tumors are associated with different underlying mechanisms and patient outcomes.
Conclusions:
- Colorectal cancer heterogeneity is explained by distinct molecular pathways.
- Identifying these pathways and subgroups can inform targeted therapies and improve prognostic accuracy.
Related Concept Videos
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
01:25Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
01:30Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
02:59Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
01:23Renewal of Intestinal Stem Cells
3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K